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Fucoidan interferes with Porphyromonas
gingivalis-induced aneurysm enlargement by
decreasing neutrophil activation
Jean-Marc Alsac, MD,a,b Sandrine Delbosc, PhD,a Martin Rouer, MD,a,b Clément Journé, MSc,a
Liliane Louedec, MSc,a Olivier Meilhac, PhD,a and Jean-Baptiste Michel, MD, PhD,a Paris, France
Purpose: Neutrophils have been shown to be involved in all stages of human and experimental abdominal aortic aneurysm
(AAA) development. The initial processes of neutrophil rolling and trapping in the intraluminal thrombus (ILT) are
mediated mainly by P-selectin expressed by activated platelets. In the present study, we propose to evaluate the beneficial
effect of fucoidan, a competitive binding agent of P-selectin, on aneurysmal growth in a rat model of aortic aneurysm with
neutrophil enrichment of the ILT induced by repeated episodes of weak bacteremia.
Methods: Sixty Lewis rats with experimental AAAs, developed from decellularized aortic xenografts, were divided into four
groups. Two groups were used as controls: group fucoidan control (FC) was treated with 200 mg of fucoidan (F) delivered by
2 mL, 4-week osmotic pumps placed intraperitoneally before closing the abdomen, and group C received saline instead of
fucoidan. Two more groups were injected weekly with Porphyromonas gingivalis (P. gingivalis [Pg]): group FPg received
200 mg of intraperitoneal fucoidan and group Pg received saline. AAAs were harvested after 4 weeks and peripheral blood was
sampled at that time. Cell-free DNA (cf-DNA) and myeloperoxydase (MPO) antigen concentrations were determined in
plasma and in AAA-conditioned media. Histology and P-selectin immunostaining were performed on AAA tissue samples.
Results: Comparing rats injected with Pg, those receiving fucoidan presented reduced aneurysmal diameter. Histologic
analysis of AAAs showed that fucoidan reduced the ILT thickness in Pg-injected rats, with fewer trapped neutrophils, and
with signs of a healing process, as observed in control group C. Immunohistological analysis revealed a substantial
decrease in P-selectin immunostaining at the luminal surface of aneurysms in fucoidan-treated rats compared to the other
groups, suggesting an interaction between fucoidan and P-selectin. A significant decrease in MPO concentrations in both
plasma and conditioned medium was induced by fucoidan treatment in Pg-injected rats, reflecting a pacification of the
ILT biological activity. This effect was associated with a reduction in neutrophil activation and apoptosis, reflected by a
significant decrease in cf-DNA concentration in both plasma and conditioned medium of fucoidan-treated rats.
Conclusions: Our results suggest that fucoidan has a beneficial effect on experimental aneurysmal degeneration by
decreasing neutrophil activation in the ILT enhanced by weak pathogen contamination. This effect seems to be related to
its interaction with P-selectin, which may decrease the trapping of neutrophils into the ILT. Fucoidan could represent a
therapeutic option in AAAs to decrease the neutrophil activation involved in the degenerative process of aneurysmal
expansion and rupture. ( J Vasc Surg 2013;57:796-805.)
Clinical Relevance: In the present study, we propose to evaluate the beneficial effect of fucoidan, a competitive binding agent
of P-selectin, on aneurysmal growth in a rat model of aortic aneurysm with neutrophil enrichment of the intraluminal
thrombus induced by repeated episodes of weak bacteremia. Our results suggest that fucoidan has a beneficial effect on
experimental aneurysmal degeneration enhanced by weak pathogen contamination by decreasing the trapping of neutrophils
and the release of proteolytic enzymes into the intraluminal thrombus. Fucoidan could, therefore, represent a therapeutic
option in abdominal aortic aneurysm to decrease the degenerative process leading to aneurysmal expansion and rupture.
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0Neutrophils have been shown to be involved in the
early and late stages of human and experimental abdominal
aortic aneurysm (AAA) development.1,2 Their adhesion to
intraluminal thrombus (ILT) prevents ILT colonization by
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Volume 57, Number 3 Alsac et al 797Moreover, we demonstrated in a recent study that a periodon-
tal pathogen (Porphyromonas gingivalis [P. gingivalis]) en-
hances the development of AAAs in a rat model by promoting
the presence of a neutrophil-rich ILT, leading to a pathophys-
iological pattern similar to that observed in humans.7
Neutrophil recruitment in the ILT is a multistep pro-
cess that typically consists of initial neutrophil rolling on
activated platelets, leading to their trapping in the platelet-
rich fibrin network,8 and their subsequent death, causing
release of the proteolytic content of their granules.9,10 The
initial processes of neutrophil rolling and trapping in ILT
are mediated mainly by P-selectin expressed by activated
platelets11,12 and its counter receptor the P-selectin glyco-
protein ligand-1 on the neutrophil surface.13,14
Early studies,15-18 and a recent study by our group,19
have demonstrated the high affinity of fucoidan for P-
selectin, as well as its ability to bind to the platelet-rich ILT
in vivo.20 Fucoidan has been reported to prevent selectin-
dependent recruitment of leukocytes by the activated en-
dothelium in experimental ischemia-reperfusion (Morya et
al21 for review). Nevertheless, the in vivo potential benefi-
cial effect of fucoidan on leukocyte-thrombus interactions
has never been tested. In the present study, we propose to
evaluate the potential benefit of fucoidan as a competitive
binding agent of P-selectin, and to assess its effect on
aneurysmal growth in a recently described rat model of
aortic aneurysm characterized by a neutrophil-rich ILT
induced by repeated episodes of weak bacteremia.7
METHODS
Experimental model of AAA. Experimental AAAs
were induced by implanting a segment of decellularized
guinea pig aorta in the rat as previously described.22 Briefly,
under intraperitoneal pentobarbital anesthesia, guinea pig
infrarenal aortas (1.5 cm) were sampled and decellularized
by sodium dodecyl sulfate treatment (0.1%; overnight
4°C). After washing in saline, aortas were orthotopically
transplanted into the abdominal aorta of the Lewis rat.
Postoperatively, animals were fed a standard diet and their
care complied with the principles of Laboratory Animal
Care formulated by the European Union. This experimen-
tation was carried out under the authority of the French
Ministry of Agriculture (authorization n° 75-214, deliv-
ered March 25, 2003). This model is characterized by an
initial immune injury of the xenogenic extracellular ma-
trix,22 and a secondary spontaneous healing process, which
can be accelerated by smooth muscle cells seeding.23
P. gingivalis culture. P. gingivalis strain was purchased
from the Collection de l’Institut Pasteur (Paris, France) and
was grown on M20 medium, consisting of 3% (w/v) tryp-
tone, 1.5% (w/v) agar, 2% (w/v) yeast extract, 0.05%
(w/v) cysteine hydrochloride, 05% (w/v) glucose, 2.5%
(v/v) hemin solution (0.1% (w/v) hemin chloride, 4%
(v/v) triethanolamine), in an anaerobic chamber at 37°C
(Bio-Merieux, Lyon, France). Bacteria were subcultured
once a week. A total of 1 mL of the cell suspension was
centrifuged (5000 g, 5 minutes) and resuspended in 12 mL
of M20 medium. Weekly injections of P. gingivalis in the mbove-described model prevent the spontaneous healing
rocess.7
Experimental study design. Sixty male Lewis rats
nd 60 guinea pigs were used for this study. Simultane-
usly with transplantation (D0), the rats were randomly
llocated to:
● Group C (control) who received 2 mL of saline via a 2
mL, 4-week osmotic pump (Model 2ML4, Alzet, Cu-
pertino, Calif) placed intraperitoneally, immediately
after xenografting, before closing the abdomen.
● Group Pg (P. gingivalis) who received 2 mL of saline
in a 2 mL, 4-week osmotic pump as in group C and P.
gingivalis (107 colony forming units [CFUs]/500
L/rat), injected once a week via the jugular vein for 4
weeks.
● Group FC (fucoidan control) who received 200 mg of
fucoidan in a 2 mL, 4-week osmotic pump placed
intraperitoneally.
● Group FPg (fucoidan  P. gingivalis) who re-
ceived 200 mg of fucoidan in a 2 mL, 4-week
osmotic pump as for group FC and P. gingivalis (107
CFU/500 L/rat) injected once a week for 4 weeks
as for group Pg.
After 4 weeks of treatment, rats were anesthetized by
ntraperitoneal pentobarbital injection. Blood was col-
ected in citrated tubes; the maximal diameter of the AAA
as measured in vivo using a grid in the microscope eye-
iece before its removal for further study. For each animal,
he harvested aneurysmal tissue was divided in two parts:
ne for histologic analysis and one for biochemical analysis
n conditioned media. The aneurysmal wall was fixed in
araformaldehyde (3.7%) for immunohistochemical analy-
is or incubated for 24 hours in Roswell Park Memorial
nstitute medium1640 at 37°C (Invitrogen, Cergy-Pon-
oise, France) (6 mL/g of wet tissue), in order to obtain
onditioned medium. The conditioned medium was cen-
rifuged at 3000 g for 10 minutes at 20°C and the super-
atant was then aliquoted and stored at 80°C until use.
Plasma neutrophil counts. Neutrophils were quanti-
ed in peripheral blood using a Scil Vet ABC animal blood
ounter (SCIL Animal Care Company GmbH, Viernheim,
ermany). Counts were expressed as 103/L of blood.
Determination of cell-free DNA concentrations.
ell-free DNA (cf-DNA) concentration was determined in
he conditioned medium of experimental AAA samples and
n rat plasma, using Quant-it Picogreen dsDNA Reagent
Invitrogen). Briefly, 10 L of samples and Lambda DNA
tandard (1 ng/mL1 g/mL) were diluted in TE buffer
200 mM Tris-HCl, 20 mM EDTA, pH7.5, 100-L final)
efore addition of 100L Picogreen dsDNA reagent. After
ixing and incubation for 5 minutes at room temperature
n the dark, the fluorescence was measured using a micro-
late reader (excitation 480 nm, emission 520 nm).
Determination of myeloperoxidase antigen con-
entrations. The concentration of myeloperoxidase (MPO)
ntigen, a marker of neutrophil activation,10 in conditioned
edium and in plasma of rats was determined using the rat
6
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March 2013798 Alsac et alMPO enzyme linked immunosorbent assay kit from Hycult
Biotechnology (Uden, The Netherlands).
Histology and immunostaining. After euthaniza-
tion (28 days), relevant tissue of each samples were fixed
in paraformaldehyde for 24 hours, embedded in paraffin,
and cut into 5-m sections for morphologic analysis.
Serial sections were stained with Masson trichrome and
hematoxylin & eosin to visualize cells, nuclei and fibrin,
and with orcein to show elastin fibers and internal elastic
lamina. Immunostaining was performed on deparaf-
finized sections incubated with a primary goat antimouse
P-selectin antibody (SC 6943; Santa Cruz Biotechnology,
Santa Cruz, Calif) (1/50) revealed by a secondary rabbit
antigoat immunoglobulin G (Dako P0160; Dako North
America, Carpinteria, Calif) (1/200), followed by the 3,3-
diaminobenzidine reaction, and counterstaining with
Mayer hematoxylin.
Immunofluorescence. The 4=,6=-diamidino-2-
phenylindole hydrochloride (DAPI) (100 ng/mL) was
added for 15 minutes on deparaffinized sections and slides
were mounted using Fluoprep mounting medium (Dako)
to visualize nuclear, and extranuclear DNA. Primary mono-
clonal antibody anti--smooth muscle actin (1/60;
-SMA; Dako) was used to visualize smooth muscle cells of
mesenchymal cells in the aortic wall.
Statistical analysis. The study was designed with 80%
power to detect a relative 50% difference in aneurysmal size
between P. gingivalis and fucoidan  P. gingivalis groups.
Statistical testing was performed at the two-tailed (alpha)
level of 0.05 using a nonparametric Mann-Whitney U test.
Based on preliminary data indicating that the average an-
eurysmal size of Pg-injected rats at 5 weeks after xenograft
surgery was 7.62 mm, SD: 1.4, we used 15 rats for each
group (Saline; Pg; fucoidan  saline; fucoidan  Pg). A
computer-based randomization was used to allocate fu-
coidan or saline pump and P. gingivalis or saline injection
to each rat.
Results are expressed as box plots in which the boxes
represent the 25th and 75th percentiles, the line within the
box represents the median value, and the lines outside the
boxes represent the 5th and the 95th percentiles. Compar-
isons between groups were performed by two-way analysis
of variance (ANOVA) as appropriate, followed by a post
hoc Bonferroni test (Prism 5; GraphPad Software Inc, San
Diego, Calif) for intergroup pairwise comparisons. Statisti-
cal significance was accepted when P  .05.
RESULTS
Repeated episodes of P. gingivalis bacteremia in-
duce neutrophil activation and aneurysmal growth. In
order to confirm that P. gingivalis bacteremia impacts
aneurysmal progression, we used an experimental xeno-
graft-induced model of aneurysm in the rat. To mimic the
transitory repeated bacteremia associated with periodontal
disease, P. gingivaliswas injected intravenously once a week
for 4 weeks (107 CFU/rat). P. gingivalis injections induced
a significant increase in aneurysm maximal diameter as
compared to saline-injected control rats (Fig 1; group Pg: b.459  1.789 mm vs group C: 4.027  1.485 mm; P 
001).
Circulating neutrophils were significantly increased in
lood samples of rats injected weekly with P. gingivalis
ompared to group C (Fig 2; group Pg: 5.881  1.593 vs
roup C: 2.123  1.123; P  .05). This effect of P.
ingivalis bacteremia on circulating neutrophils was inde-
endent of fucoidan treatment, as shown by the lack of
nteraction in two-way ANOVA analysis (Table).
To further demonstrate neutrophil activation in the
neurysmal wall of P. gingivalis injected rats, MPO
oncentrations were measured in plasma and in the
onditioned medium. The MPO concentration was
trongly increased in plasma and in AAA-conditioned
edium of P. gingivalis-injected rats compared to those
f noninjected rats (Fig 3, A; in plasma; group Pg: 1764
7.76 vs group C: 1282  150.3; P  .001; Fig 3, B; in
onditioned medium; group Pg: 1456 150.6 vs group C:
92.2  77.56; P  .001).
Moreover, cf-DNA concentration was increased in
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rowth induced by Porphyromonas gingivalis (P. gingivalis [Pg])
njections. Maximal abdominal aortic aneurysm (AAA) diameters
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Volume 57, Number 3 Alsac et al 799ceived P. gingivalis (Fig 4, A; in plasma; group Pg: 1080
190 vs group C: 492.3  190.3; P  .001; Fig 4, B; in
conditioned medium; group Pg: 5853  500 vs group C:
4481  1101; P  .01).
Histologic analysis of Pg-injected AAAs confirmed the
thrombus formation on Masson Trichrome staining (Fig 5,
A), inside a degraded internal elastic lamina on orcein
staining (Fig 6, A), with an enrichment of neutrophil
polynuclear cells at the luminal layer of the ILT on hema-
toxylin & eosin staining (Fig 6, C) and on DAPI immuno-
fluorescence (Fig 7, A). Cf-DNA probably corresponding
to neutrophil extracellular traps (NETs) could also be
visualized in deeper layers of the ILT (Fig 7, E), signing a
neutrophil activation in the ILT of Pg injected experimen-
tal AAA.
Intraperitoneal fucoidan treatment inhibits neutro-
phil activation and aneurysmal growth induced by P.
gingivalis bacteremia. In order to provide a proof of
concept that fucoidan may inhibit thrombus/neutrophil/
bacteria interactions, we inserted an intraperitoneal os-
motic pump that continuously released 200 mg of fucoidan
throughout the 4 weeks of the experiment. This treatment
by fucoidan had no significant impact on noninjected AAA
diameter compared to controls (Fig 1; group F: 4.343 
1.645 mm vs group C: 4.027  1.485 mm; P  .5),
circulating neutrophil level (Fig 2; group F: 2067 0.5437
vs group C: 2123  1123; P  .5), MPO concentrations
(Fig 3, A; in plasma; group F: 1233  99.30 vs group C:
1282  150.3; P  .5; Fig 3, B; in conditioned medium;
group F: 944.2  75.15 vs group C: 892.2  77.56; P 
.5), or cf-DNA (Fig 4, A; in plasma; group F: 440.3 
103.8 vs group C: 492.3  190.3; P  .5; Fig 4, B; in
conditioned medium; group F: 4847  1386 vs group C:
4481  1101; P  .5).
In the two groups of P. gingivalis-injected rats, those
receiving 200 mg of fucoidan over the experimental
period of 4 weeks showed smaller aneurysmal diameters,
Table. Statistical values: the dependence of the effect of
fucoidan on Porphyromonas gingivalis bacteremia was
evaluated by two-way ANOVA analysis
Two-way ANOVA Fucoidan Pg Interaction
AAA diameter f 	 5.01 f 	 11.87 f 	 9.43
P 	 .029 P 	 .0011 P  .01
Circulating neutrophils f 	 0.02 f 	 19.95 f 	 1.45
P 	 .87 P  .001 NS
MPO Ag in plasma f 	 28.39 f 	 38.10 f 	 18.20
P  .0001 P  .0001 P  .001
MPO Ag in conditioned
media
f 	 12.79 f 	 103.75 f 	 24.75
P  .001 P  .0001 P  .0001
Cf-DNA in plasma f 	 8.39 f 	 86.87 f 	 3.62
P  .01 P  .0001 NS
Cf-DNA in conditioned
media
f 	 1.68 f 	 7.17 f 	 7.51
P  .05 P  .01 P  .01
AAA, Aortic abdominal aneurysm; ANOVA, analysis of variance; cf-DNA,
cell-free DNA concentration; MPO Ag, myeloperoxydase antigen concen-
tration; Pg, Porphyromonas gingivalis.reflecting inhibition of aneurysmal growth (Fig 1; group gPg: 4480 1645 mm vs group Pg: 6.459 1.789 mm;
 .01). This effect of fucoidan on AAA diameter was
trongly dependent on P. gingivalis bacteremia, as shown
y a significant interaction in the two-way ANOVA analysis
Table).
Histologic analysis showed that fucoidan reduced the
LT thickness in AAAs of Pg-injected rats (Fig 6, A and B),
ith fewer trapped neutrophils (Fig 6, D), preservation of
he elastic fiber network (Fig 6, A and B), and signs of a
ealing process (ie, colonization by -actin positive mesen-
hymal cells as observed in immunofluorescence) (Fig 7,
). Fucoidan also seemed to induce a substantial decrease
n P-selectin immunostaining at the luminal surface of ILT
ompared to the Pg alone (Fig 6, E and F).
A strong significant decrease in MPO concentrations in
oth plasma and conditioned medium was induced by
ucoidan treatment in Pg-injected rats, reflecting a pacifica-
ion of biological activity in the ILT (Fig 3, A; in plasma;
roup Pg: 1764  57.76 vs group FPg: 1321  180.1;
 .001; Fig 3, B; in conditioned medium; group Pg:
456  150.6 vs group FPg: 1138  97.97; P  .001).
his effect of fucoidan on MPO concentrations, reflecting a
ecrease in neutrophil activation in the conditioned me-
ium and in plasma, was strongly dependent on P. gingi-
alis bacteremia, as shown by a significant interaction in the
wo-way ANOVA analysis (Table).
This effect was associated with a reduction in neutro-
hil recruitment and apoptosis, reflected by a significant
ecrease in cf-DNA concentrations in both plasma and
onditioned medium of fucoidan-treated rats (Fig 4, A; in
lasma; group Pg: 1080 189.7 vs group FPg: 828.7
31.7; P  .05; Fig 4, B; in conditioned medium; group
g: 5853  499.7 vs group FPg: 4838  824.1; P 
05). An interaction between fucoidan treatment and
. gingivalis bacteremia was found to be significant by
wo-way ANOVA analysis of cf-DNA concentrations in
onditioned media, but did not reach significance in plasma
Table). Extra nuclear DNA could also be visualized into
he ILT of Pg injected AAA on DAPI staining, whereas
nly nuclear DNA was detected after fucoidan treatment
Fig 7, E and F).
ISCUSSION
This study shows that the intraperitoneal perfusion of
00 mg of fucoidan over a period of 4 weeks prevented the
LT-dependent enhancement of AAA dilatation induced
y weekly repeated episodes of P. gingivalis bacteremia in a
at experimental model. This impact of fucoidan seems to
e related to an interaction with P-selectin, which decreases
eutrophils activation, and the release of their proteolytic
nzymes and cf-DNA into the ILT. This could represent a
herapeutic option in order to decrease the degenerative
rocess of aneurysmal expansion, which inevitably leads to
upture in patients with an atherothrombotic AAA involv-
ng neutrophil recruitment.23
We developed a model of arterial aneurysm forma-
ion by taking advantage of the immunogenicity of
uinea pig aortic extracellular matrix grafted into
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March 2013800 Alsac et alrats.22,24 During the rejection of the xenografted extracel-
lular matrix, monocyte/macrophages and T lymphocytes
penetrate into the graft media where immunoglobulins are
deposited. Elastin in the media is degraded and the graft
dilates and becomes aneurysmal by 1 month after engraft-
ment.22 During aneurysm formation in this model, the
gelatinolytic and elastinolytic matrix metalloproteinase
(MMP)-9 is upregulated.25 In this respect, this xenograft
model reproduces the main features of the human disease
(arterial dilation and rupture, elastin degradation, inflam-
matory cell infiltration in the media, and upregulation of
MMPs). This animal model is characterized by the forma-
tion of a thrombus, about 1 week after grafting the decel-
lularized guinea pig aorta in the abdominal position in rats
and associated with aortic dilation. In this model, like in all
currently used AAA models, in the absence of additional
aggression the mural thrombus is colonized by mesenchy-
mal cells, initiating a healing process. In contrast, after 4
weekly intravenous injections of P. gingivalis, the aortic
A
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Fig 3. The increased myeloperoxydase (MPO) concen
(AAA)-conditioned media (B) induced by Porphyromon
inhibited by intraperitoneal administration of fucoidan. R
(one-way analysis of variance [ANOVA], Bonferroni test
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Fig 4. Increased cell-free DNA (cf-DNA) in plasma (A
(B) of Porphyromonas gingivalis (P. gingivalis [Pg])-injec
release. Results are presented as box plots with median.
variance [ANOVA], Bonferroni test). C, Control; FC, fudiameter was not only increased relative to saline-injected sats, but the composition of the AAA wall was also strik-
ngly different. In P. gingivalis-injected rats, the mural ILT
as persistent and exhibited a multilayered aspect, similar
o that observed in human AAA. The ILT was considerably
nriched in neutrophils and all markers of their activation
ere increased in conditioned medium and in plasma of P.
ingivalis-injected vs saline-injected rats.
In a previous study, we have demonstrated that stimu-
ation of neutrophils by P. gingivalis led to NETs produc-
ion, reflected by an increased cf-DNA concentration in the
upernatant.7 The presence of NETs in AAA samples was
lso associated with a release of cf-DNA measurable in
onditioned medium (thrombus and adventitia) and in-
reased in plasma of patients with AAAs relative to control
ubjects. In addition, concentration of cf-DNA was posi-
ively correlated with the abdominal aortic diameter, sug-
esting that this marker was a good reflection of the neu-
rophil activity in the thrombus. Neutrophils entrapped in
he luminal pole of the ILT of AAAs release proteinases
B
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Volume 57, Number 3 Alsac et al 801provided the evidence that neutrophil elastase adsorbed in
the fibrin matrix can prevent recolonization of the throm-
bus by both smooth muscle cells and mesenchymal cells.
These data pointed to new therapeutic strategies involving
the possible use of neutrophil activation inhibitors allowing
cellular healing of ILT, therefore, preventing aneurysm
evolution.
Several lines of evidence led us to hypothesize that
bacteria and particular periodontal pathogens may par-
ticipate in the development of AAAs. Epidemiologic data
suggest a potential association between periodontal and
cardiovascular diseases.26 The nature of this association
is, however, still debated; in particular, whether peri-
odontal disease impacts directly on the pathogenesis of
cardiovascular disease or indirectly by increasing inflam-
mation background is not settled. Interestingly, athero-
thrombosis and periodontal diseases share risk factors
such as age, gender, hypertension, and smoking. Gender,
age, and smoking are the most important risk factors for
AAAs.27,28 Heretofore, no epidemiologic study has been
performed potentially linking AAA development and
periodontal disease.
As previously described, this P. gingivalis periodontal
pathogen enhances the development of AAAs by maintain-
ing the presence of a neutrophil-rich ILT, leading to a
pathophysiological pattern similar to that observed in hu-
mans.7 We believe that this experimental model provides
the opportunity to test new therapeutic agents specifically
directed against neutrophil binding and activation within
the ILT. Antibiotics such as doxycycline have already
Fig 5. After fixing in paraformaldehyde, abdominal
gingivalis (P. gingivalis; Pg) (A) and group fucoidan (F)
histology. Slides were stained with Masson Trichrome an
induced neutrophil recruitment, thrombus enlargement,
thrombus (ILT) thickness in Pg-injected rats, with less nshown a potential impact on aneurysmal stabilization, due, ft least in part, to neutrophil rarefaction.29,30 In one of our
receding studies,3 we demonstrated that neutrophils rep-
esent the major impediment to ILT recolonization by
esenchymal cells in human AAA. Therefore, characteriz-
ng agents that inhibit neutrophil interactions with platelet-
ich fibrin and their subsequent trapping in the ILT could
e of great interest to promote the healing process in the
neurysmal vascular wall. We and others have pointed out
he potential mediators of neutrophil recruitment, such as
-selectin and P-selectin,31,32 and chemoattractants such
s regulated on activation, normal T expressed and secreted
ytokine (RANTES), interleukin-8, and leukotriene B4.33
n the cardiovascular context, P-selectin expression is in-
olved in the pathophysiology of the renewal and growth of
iologically active thrombi in arterial atherothrombotic
laques.8 P-selectin promotes interactions between plate-
ets, bacteria, and leukocytes,6 representing an important
olecular target in the regulation of thrombus-dependent
ortic wall degenerative processes.
Many studies have shown that mimics of sialyl Lewis X
SLeX), oligosaccharides, and sulfated polysaccharides such
s heparan and fucoidan, or some of their derivatives, are
ble to interact with P-selectin.13,29,34 Fucoidan, a type of
ulfated polysaccharide derived from brown seaweed, is a
aturally occurring mimic of SLeX,35 which is the natural
igand of P-selectin.36 Our group recently demonstrated
he high affinity of fucoidan for P-selectin,19 as well as its
ow nonspecific binding.20 We showed that low molecular
eight fucoidan prevented P-selectin binding to SLeX with
anomolar concentration range. Moreover, the binding of
aneurysm (AAA) samples of group Porphyromonas
B) were embedded in paraffin and sectioned at 5 m for
lyzed at1.25 and 40, as presented. A, Pg injections
nhibited healing. B, Fucoidan reduced the intraluminal
phil trapping, and organizing thrombus.aortic
Pg (
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and iucoidan to human platelets increased with the level of
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March 2013802 Alsac et alplatelet activation, and the binding of anti–P-selectin anti-
body to activated platelets was inhibited by fucoidan.19
Therefore, we used fucoidan-containing compound as a
contrast agent for imaging ILT in experimental models of
AAA in rats.20 These data suggested the ability of fucoidan
to target P-selectin in ILT.
Fucoidan seems to have a localized action on neutrophil
activation in the ILT, at the level of the AAA, as a strong
interaction between fucoidan treatment and P. gingivalis-
induced neutrophil activation could be demonstrated on
AAA diameter, MPO concentrations in both conditioned
media and plasma, as on cf-DNA in conditioned media, but
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Fig 6. A preservation of the elastic fiber network is ind
thrombus can be seen inside the degraded internal elast
group (A). A qualitative indication of neutrophil increase
Pg group compared to the fucoidan (F)Pg group is give
D). P-selectin immunostaining was decreased at the lumi
suggesting an interaction between fucoidan and P-selec
group Pg (E), and group FPg (F) are presented with hnot on circulating neutrophil counts or on cf-DNA con- tentrations in plasma, suggesting a more specific action of
ucoidan at the level of the ILT rather than a systemic effect
n neutrophils.
Fucoidan is also able to inhibit adhesion of some bac-
erial species to endogenous glycoproteins, such as Esche-
ichia coli,37 Streptococcus,38 Helicobacter pylori,39 and
taphylococcus,40 and therefore to limit their infectious in-
asiveness. An effect of fucoidan on P. gingivalis has never
een reported, and was not analyzed in our study. How-
ver, we cannot exclude that fucoidan may have an addi-
ional direct effect on the adhesion of P. gingivalis to the
LT, which could also play a role in limiting neutrophil
FPg
B
D
F
by fucoidan on orcein-stained slides at 40 (B), and
ina in the Porphyromonas gingivalis (P. gingivalis; Pg)
ber in abdominal aortic aneurysm (AAA) sections of the
hematoxylin & eosin staining at20 and100 (C and
rface of aneurysmal aortic walls in fucoidan-treated rats,
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Volume 57, Number 3 Alsac et al 803Fucoidan has been extensively studied for its diverse
biological activities. However, there is no detailed report
investigating its toxicity. In a study by Li et al,41 the acute
and chronic (6 months) toxicity of varying levels of fu-
coidan was investigated in Wistar rats after oral administra-
tion.41 The results showed that no significant toxic changes
were observed when 300 mg/kg body weight per day of
fucoidan was administered to rats. However, when the dose
was increased to 900 and 2500 mg/kg body weight per
day, the clotting time was significantly prolonged. Besides
this, no other signs of toxicity were observed. Based on
these results, it can be concluded that there is no adverse
effect level of fucoidan at 300 mg/kg body weight per day.
P. gingivaliswere injected at the dose of 107 CFU/500
A
C
C
E
Pg
Fig 7. A qualitative indication of neutrophil increased n
in the Porphyromonas gingivalis (P. gingivalis; Pg) gr
confirmed after 4=,6=-diamidino-2-phenylindole hydroch
of the abdominal aortic aneurysm (AAA) treated by fucoid
the aortic wall at 40 of the FPg group (D) com
recolonization. Extranuclear DNA is visualized on DA
suggesting an enhanced neutrophil activation, whereas onL/rat, without providing any septic sign, and represent- png 20 times more than the dose injected of Staphylococcus
ureus to induce an aortic endocarditis in rats.42 Pathogens
f the subgingival plaque can easily reach the bloodstream
everal times a day via chewing and brushing teeth, espe-
ially in patients with periodontal disease. Chronic bactere-
ia could, therefore, provide a subclinical infection of
arious cardiovascular tissues, such as thrombus of the
AA. P. gingivalis is a strict anaerobic bacterium that
annot proliferate in the mural thrombus. It is therefore a
eak pathogen by itself, but induces neutrophil activation
etrimental to the healing of the aneurysm.
Limitations and conclusions. Our study provides ex-
erimental data based on a recently developed model of
AAs with a neutrophil-rich ILT relevant to human patho-
FPg
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D
F
r at the luminal portion of intraluminal thrombus (ILT)
(A) compared to the fucoidan (F)Pg group (B) is
(DAPI) fluorescence at40. Signs of a healing process
e confirmed by the high density of actin stained cells into
d to the Pg group (C), suggesting a mesenchymal
orescence 40, in the ILT of Pg injected AAAs (E),
clear DNA is seen in the fucoidan-treated aortic wall (F).umbe
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March 2013804 Alsac et allinking AAAs and periodontal diseases would be necessary
to support our findings. The model used is a decellularized
xenograft transposition characterized by the formation of a
thrombus after 1 week. The healing process induced by
mesenchymal cell colonization of the aneurysmal wall, that
usually takes place thereafter in the absence of additional
injury, has been considered to be the main limitation of
experimental AAAs in small animals, as this process is not
observed in human evolutive AAAs. Now that the implica-
tion of weak pathogens, such as P. gingivalis, has been
described to explain the recurrent enrichment in neutro-
phils of the ILT, this limitation, represented by the fibrotic
cicatrization of the aneurysmal wall, could be considered as
a goal to reach in treating human AAAs. Our results suggest
that fucoidan induces this reversal effect on experimental
aneurysmal degeneration by decreasing Pg-dependent neu-
trophil activity in the ILT.
The authors thank Dr Mary Osborne-Pellegrin for
editing the manuscript.
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